KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,504 | +349.0% | 47,183 | +466.7% | 0.02% | +466.7% |
Q2 2023 | $335 | -72.0% | 8,326 | -70.3% | 0.00% | -78.6% |
Q1 2023 | $1,198 | +77.0% | 28,054 | +98.9% | 0.01% | +75.0% |
Q4 2022 | $677 | -99.8% | 14,105 | +75.7% | 0.01% | +100.0% |
Q3 2022 | $302,000 | -14.7% | 8,026 | -37.3% | 0.00% | 0.0% |
Q2 2022 | $354,000 | +121.2% | 12,797 | +334.7% | 0.00% | +300.0% |
Q1 2022 | $160,000 | +1.3% | 2,944 | +9.0% | 0.00% | 0.0% |
Q4 2021 | $158,000 | -45.1% | 2,701 | -62.9% | 0.00% | 0.0% |
Q3 2021 | $288,000 | +71.4% | 7,283 | +167.3% | 0.00% | 0.0% |
Q1 2021 | $168,000 | +9.8% | 2,725 | -33.3% | 0.00% | 0.0% |
Q2 2020 | $153,000 | – | 4,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |